Some scientists have also reported that the application of the antitumor drug didox, a derivative of hydroxyurea, can target RRM2 and inhibit its activity by quenching tyrosine free radicals at the enzyme active site, thereby suppressing the proliferation of liver cancer cells. Here, RRM2 is linked to liver cancer.